Blood Collection Market Introduction and Overview
According to SPER Market Research, the Global Blood Collection Market is estimated to reach USD 9.08 billion by 2034 with a CAGR of 8.93%.
The report includes an in-depth analysis of the Global Blood Collection Market, including market size and trends, product mix, Applications, and supplier analysis. The global blood collection market was valued at USD 3.86 billion in 2024 and is expected to grow at a rate of 8.93% from 2025 to 2034. This growth is driven by more diagnostic procedures using blood samples, including disease screening and medication monitoring. Regular blood tests are important for evaluating and monitoring chronic illnesses like diabetes, cardiovascular disease, and cancer. The rise in chronic diseases will likely increase the need for diagnostic testing and blood collection equipment.
By Collection Site Insights: The venous segment led the market in 2024, holding the largest revenue share. There is an increasing demand for venous blood collection due to the need for detailed diagnostic testing in healthcare. As chronic diseases like diabetes, heart conditions, and cancer rise, more routine and advanced blood tests are needed, many requiring venous samples. Venous collection allows for larger samples for multiple tests from one draw, which is important for complex health cases. Additionally, the growth of decentralized trials and home health services boosts the demand for venous collection for reliable remote patient monitoring.
By Application Insights: Diagnostics held a major share of the market in 2024 and is expected to grow the fastest in the coming years, due to the rising demand for accurate, quick, and less invasive testing in healthcare. Blood collection for diagnostics is vital for detecting various medical issues, including common infections and chronic diseases. A notable example is blood tests for diabetes management, where regular blood draws track glucose levels and inform treatment.
By Method Insights: The manual blood collection segment led the market with a large share in 2024, mainly due to its common use in different healthcare settings, from primary care to specialized clinics, where reliable and affordable blood collection is important. Manual methods offer healthcare providers more control and flexibility, especially for patients with difficult vein access, including children and the elderly. This method is still popular in areas with limited access to advanced automated systems.
By End User Insights: The hospitals segment had a large market share in 2024. Hospitals and clinics serve many patients daily, performing routine blood tests, emergency care, and surgeries. The frequent blood tests create steady demand for vacuum blood collection tubes. Additionally, rising healthcare spending in developing countries is resulting in new hospital construction and upgrades to current facilities.
Regional Insights: In 2024, North America dominated the blood collection industry, accounting for the majority of revenue. Several factors are driving the expansion of the North American market, including an increase in the number of accidents, a rise in the frequency of chronic and lifestyle diseases, and a growing elderly population.
Market Competitive Landscape:
The blood collection industry is competitive, involving large global firms and smaller companies vying for market share. Success relies on regularly introducing new products and technologies. Major players greatly influence the market through significant R&D investments. Strategic partnerships and mergers and acquisitions are vital for expanding reach, though strict regulations pose challenges for newcomers. Key market players are Abbott, NIPRO Medical Corporation, BD, Terumo Corporation; Medtronic, QIAGEN, FL Medical s.r.l, Greiner AG, Haemonetics Corporation, F. Hoffmann-La Roche Ltd, Sarstedt AG & Co KG, Centogene N.V, SEKISUI CHEMICAL CO, LTD.
Recent Developments:
- In April 2024, Becton, Dickinson, and Company launched the BD Vacutainer UltraTouch push button blood collection set in India. This device uses BD RightGauge technology for a thinner needle and BD PentaPoint Technology to reduce insertion pain, enhancing patient comfort and blood collection efficiency.
- In December 2023, BD (Becton, Dickinson & Company) announced it received 510(k) clearance from the U. S. Food and Drug Administration (FDA) for a new blood collection device that obtains samples through a fingerstick.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Collection Site, By Application, By Method, By End User. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Abbott, NIPRO Medical Corporation, BD, Terumo Corporation; Medtronic, QIAGEN, FL Medical s.r.l, Greiner AG, Haemonetics Corporation, F. Hoffmann-La Roche Ltd, Sarstedt AG & Co KG, Centogene N.V, SEKISUI CHEMICAL CO, LTD. and others. |
Key Topics Covered in the Report:
- Global Blood Collection Market Size (FY’2021-FY’2034)
- Overview of Global Blood Collection Market
- Segmentation of Global Blood Collection Market By Collection Site (Venous, Capillary)
- Segmentation of Global Blood Collection Market By Application (Diagnostics, Treatment)
- Segmentation of Global Blood Collection Market By Method (Manual, Automated)
- Segmentation of Global Blood Collection Market By End User (Hospitals, Diagnostics Centers, Blood Banks, Emergency Departments, Others)
- Statistical Snap of Global Blood Collection Market
- Expansion Analysis of Global Blood Collection Market
- Problems and Obstacles in Global Blood Collection Market
- Competitive Landscape in the Global Blood Collection Market
- Details on Current Investment in Global Blood Collection Market
- Competitive Analysis of Global Blood Collection Market
- Prominent Players in the Global Blood Collection Market
- SWOT Analysis of Global Blood Collection Market
- Global Blood Collection Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Blood Collection Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Blood Collection Market
7. Global Blood Collection Market, By Collection Site (USD Million) 2021-2034
7.1. Venous
7.1.1. Needles and Syringes
7.1.2. Double-Ended Needles
7.1.3. Winged Blood Collection Sets
7.1.4. Standard Hypodermic Needles
7.1.5. Other Blood Collection Needles
7. 2. Blood Collection Tubes
7.1.1. Serum-separating
7.1.2. EDTA
7.1.3. Heparin
7.1.4. Plasma-separating
7.1.5. Blood Bags
7.1.6. Others
7.3. Capillary
7.3.1. Lancets
7.3.2. Micro-Container Tubes
7.3.3. Micro-Hematocrit Tubes
7.3.4. Warming Devices
7.3.5. Others
8. Global Blood Collection Market, By Application (USD Million) 2021-2034
8.1. Diagnostics
8.2. Treatment
9. Global Blood Collection Market, By Method (USD Million) 2021-2034
9.1. Manual Blood Collection
9.2. Automated Blood Collection
10. Global Blood Collection Market, By End User (USD Million) 2021-2034
10.1. Hospitals
10.2. Diagnostics Centers
10.3. Blood Banks
10.4. Emergency Departments
10.5. Others
11. Global Blood Collection Market, (USD Million) 2021-2034
11.1. Global Blood Collection Market Size and Market Share
12. Global Blood Collection Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Abbott
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. NIPRO Medical Corporation
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BD
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Terumo Corporation
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Medtronic
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. QIAGEN
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. FL Medical s.r.l
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Greiner AG
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Haemonetics Corporation
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. F. Hoffmann-La Roche Ltd
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Sarstedt AG & Co. KG
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary
13.11.4. Recent developments
13.12. Centogene N.V
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary
13.12.4. Recent developments
13.13. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links